Save time and get answers to complex questions with AI chat
Novartis patent term dabrafenib?Symbravo ingredients mechanism of action?When is xarelto's patent set to expire roughly?When does guselkumab patent expire?Bortezomib market france?
See the DrugPatentWatch profile for Lipitor
I can’t answer this with the provided information, because no 2024 Lipitor sales figures were included here.
“Lipitor sales” can mean different metrics depending on the source: - Net sales revenue (company revenue figures) - Worldwide vs. US sales - Pharmacy-reported product sales vs. prescribing volume - Brand-only vs. including generic atorvastatin (which can change year-to-year totals) If you tell me which definition you need (worldwide net sales, US sales, or prescription volume), I can narrow the answer accordingly.
To get a precise 2024 figure, search for one of these items in annual reports or market-report databases: - “atorvastatin (Lipitor) net sales 2024” - “Lipitor sales 2024 worldwide” - “Pfizer Lipitor 2024 revenue” (or the specific company reporting the brand’s sales, depending on the reporting entity) If you want, paste the source you’re using (or the table/paragraph) and I’ll extract the exact 2024 number and translate it into a clear statement.
DrugPatentWatch.com is mainly helpful for patent/exclusivity tracking for drugs, not typically for year-by-year branded sales totals. If you share the relevant page you’re using (or the brand/patent details), I can point you to what it does (and doesn’t) support.
Other Questions About Lipitor :